Due to upcoming regulatory changes, compounded Tirzepatide will no longer be available after March 19, 2025, and compounded Semaglutide will be discontinued after May 22, 2025.
We wanted to give you a heads-up about some upcoming changes. If you've been enjoying the benefits of these affordable alternatives—like compounded Semaglutide, which costs as little as $195 per month compared to around $1,300 per month for Mounjaro® and Ozempic®—now's your chance to stock up!
To make the most of this final opportunity, we're offering a 10% discount on any 3-month supply of compounded GLP-1 medication purchased before the respective deadlines. If you have any questions or need help placing an order, our friendly Client Care Team is here for you. Just give us a shout!
We truly appreciate your understanding and remain committed to providing you with high-quality, cost-effective treatment options. Thanks for choosing MintRx Pharmacy for your healthcare needs.
Best, The MintRx Team
